Molecular Pharmacology and Pathology Program, Department of Pathology, University of Sydney, Sydney, New South Wales 2006, Australia.
Molecular Pharmacology and Pathology Program, Department of Pathology, University of Sydney, Sydney, New South Wales 2006, Australia.
Biochim Biophys Acta Gen Subj. 2017 May;1861(5 Pt A):995-999. doi: 10.1016/j.bbagen.2017.02.021. Epub 2017 Feb 17.
We recently demonstrated that a novel storage and transport mechanism for nitric oxide (NO) mediated by glutathione-S-transferase P1 (GSTP1) and multidrug resistance protein 1 (MRP1/ABCC1), protects M1-macrophage (M1-MØ) models from large quantities of endogenous NO. This system stores and transports NO as dinitrosyl-dithiol-iron complexes (DNICs) composed of iron, NO and glutathione (GSH). Hence, this gas with contrasting anti- and pro-tumor effects, which has been assumed to be freely diffusible, is a tightly-regulated species in M1-MØs. These control systems prevent NO cytotoxicity and may be responsible for delivering cytotoxic NO as DNICs via MRP1 from M1-MØs, to tumor cell targets.
我们最近证明,一种由谷胱甘肽-S-转移酶 P1(GSTP1)和多药耐药蛋白 1(MRP1/ABCC1)介导的新型一氧化氮(NO)储存和转运机制,可以保护 M1-巨噬细胞(M1-MØ)模型免受大量内源性 NO 的影响。该系统将 NO 储存和转运为二硝酰-二硫醇-铁配合物(DNICs),由铁、NO 和谷胱甘肽(GSH)组成。因此,这种具有相反的抗肿瘤和促肿瘤作用的气体,被认为是自由扩散的,在 M1-MØ 中是一种受到严格调控的物质。这些控制系统可以防止 NO 的细胞毒性,并且可能负责通过 MRP1 将细胞毒性 NO 作为 DNICs 从 M1-MØ 递送到肿瘤细胞靶标。